Proto Labs Inc
No enriched coverage for $PRLB in the last 7 days.
No SEC Form 4 filings for $PRLB in the last 30 days.
Proto Labs announced record Q1 2026 revenue of $139.3 million, marking a 10.4% year-over-year increase and their fourth consecutive quarter of double-digit growth. The company also improved its non-GAAP gross margin to 46.2% due to better cost control and operational efficiency. Management projects a positive outlook with anticipated full-year revenue growth of 6% to 8% for 2026.
Proto Labs Inc. (PRLB) reported a first-quarter profit of $8.1 million, or 33 cents per share. Adjusted earnings were 54 cents per share, with total revenue reaching $139.3 million. The company forecasts its per-share earnings for the current quarter ending in June to be between 50 cents and 58 cents.
Rice Hall James & Associates LLC significantly reduced its stake in Proto Labs, Inc. (NYSE:PRLB) by 16.1% during the third quarter, while other institutional investors like Rubric Capital Management LP increased their holdings. Despite the reduction by Rice Hall James, analyst sentiment remains positive with a "Moderate Buy" rating and an average price target of $53.33, following a strong Q3 earnings beat and an upgrade to "strong-buy" by Zacks. Insider Michael R. Kenison also sold a portion of his shares, but institutional investors still own a substantial 84.54% of the company's stock.
